Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2024/10/26

Curator: MyleeeA

Revision editor(s): MyleeeA, KateRasheed, WikiWorks

Source: Supplementary Figure 6

Description: Differentially Abundant taxa between the High Risk (HR)/Medium Risk (MR) and Low Risk (LR) groups With medication use determined using linear discriminant analysis effect size (LEfSe) analysis

Abundance in Group 1: increased abundance in Low Risk (LR) With Medication use

NCBI Quality ControlLinks
Aggregatibacter
Blautia
Hylemonella
Lachnospira
Lachnospiraceae
Lysinibacillus
Oscillospiraceae
Roseburia
Vagococcus
SMB53SMB53
02d0602d06
Et0H8Et0H8
Streptococcaceae bacterium RF32

Revision editor(s): MyleeeA, KateRasheed, WikiWorks